Reuters: Maryland charges Insys with engaging in deceptive opioid scheme
Reuters: Maryland charges Insys with engaging in deceptive opioid scheme
Maryland on Thursday charged Insys Therapeutics Inc with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients.
Maryland Attorney General Brian Frosh announced that he had filed administrative charges against Arizona-based Insys, which he said provided thousands of dollars in inducements to doctors to promote prescribing its medication Subsys to their patients.
The company declined comment. It has said that it has taken steps to prevent past mistakes from happening again.
Maryland alleged the company influenced doctors to prescribe the drug beyond its labeled use with inducements that included payments purported to be compensation for participating in educational events.
As attorney general, Frosh has been a faithful representative of the people’s interests, defending our rights and focusing upon the interests of citizens in need. He has also been a leader in a [...]
As attorney general, Frosh has been a faithful representative of the people’s interests, defending our rights and focusing upon the interests of citizens in need. He has also been a leader in a [...]
Maryland Attorney General (“AG”) Brian Frosh is not going down without a fight in his bid to defend a Maryland law prohibiting “price gouging” by generic pharmaceutical manufacturers. H.B. 631, 437th Gen. Assemb., [...]
